Discover 1,705 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,705
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Grand Rapids MI,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
for
Adult Acute Myeloid Leukemia
Location: Detroit MI, Cleveland OH, Cincinnati OH, Rochester NY,
Sponsor: Priothera SAS
Sex: All
Age: 18 - 70+
Code: NCT05429632
Phase3, Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
for
Nasopharyngeal Cancer Recurrent
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Toronto,
Sponsor: Coherus Oncology, Inc.
Sex: All
Age: 12+
Code: NCT06457503
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for
Primary Biliary Cholangitis
Location: Detroit MI, Cleveland OH, Columbus OH, Toronto,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06051617
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Detroit MI, Ann Arbor MI, Maumee OH, Massillon OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod